Kiniksa Insider Quart Barry D Buys $14.33‑Share, Betting Big on Phase‑3 Success
Quart Barry D’s disciplined 10b5‑1 purchase of Kiniksa shares signals strong insider conviction amid booming earnings and a promising Phase‑3 pipeline, boosting investor confidence.
- Kiniksa Pharmaceuticals International Plc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read